BACKGROUND AND PURPOSE: Activation of the proteinase-activated receptor-2 (PAR-2) induces scratching behaviour in mice. Here, we have investigated the role of kinin B(1) and B(2) receptors in the pruritogenic response elicited by activators of PAR-2. EXPERIMENTAL APPROACH: Scratching was induced by an intradermal (i.d.) injection of trypsin or the selective PAR-2 activating peptide SLIGRL-NH(2) at the back of the mouse neck. The animals were observed for 40 min and their scratching response was quantified. KEY RESULTS: I.d. injection of trypsin or SLIGRL-NH(2) evoked a scratching behaviour, dependent on PAR-2 activation. Mice genetically deficient in kinin B(1) or B(2) receptors exhibited reduced scratching behaviour after i.d. injection of trypsin or SLIGRL-NH(2). Treatment (i.p.) with the non-peptide B(1) or B(2)receptor antagonists SSR240612 and FR173657, respectively, prevented the scratching behaviour caused by trypsin or SLIGRL-NH(2). Nonetheless, only treatment i.p. with the peptide B(2)receptor antagonist, Hoe 140, but not the B(1)receptor antagonist (DALBK), inhibited the pruritogenic response to trypsin. Hoe 140 was also effective against SLIGRL-NH(2)-induced scratching behaviour when injected by i.d. or intrathecal (i.t.) routes. Also, the response to SLIGRL-NH(2) was inhibited by i.t. (but not by i.d.) treatment with DALBK. Conversely, neither Hoe 140 nor DALBK were able to inhibit SLIGRL-NH(2)-induced scratching behaviour when given intracerebroventricularly (i.c.v.). CONCLUSIONS AND IMPLICATIONS: The present results demonstrated that kinins acting on both B(1) and B(2) receptors played a crucial role in controlling the pruriceptive signalling triggered by PAR-2 activation in mice.
BACKGROUND AND PURPOSE: Activation of the proteinase-activated receptor-2 (PAR-2) induces scratching behaviour in mice. Here, we have investigated the role of kinin B(1) and B(2) receptors in the pruritogenic response elicited by activators of PAR-2. EXPERIMENTAL APPROACH: Scratching was induced by an intradermal (i.d.) injection of trypsin or the selective PAR-2 activating peptide SLIGRL-NH(2) at the back of the mouse neck. The animals were observed for 40 min and their scratching response was quantified. KEY RESULTS: I.d. injection of trypsin or SLIGRL-NH(2) evoked a scratching behaviour, dependent on PAR-2 activation. Mice genetically deficient in kinin B(1) or B(2) receptors exhibited reduced scratching behaviour after i.d. injection of trypsin or SLIGRL-NH(2). Treatment (i.p.) with the non-peptide B(1) or B(2)receptor antagonists SSR240612 and FR173657, respectively, prevented the scratching behaviour caused by trypsin or SLIGRL-NH(2). Nonetheless, only treatment i.p. with the peptide B(2)receptor antagonist, Hoe 140, but not the B(1)receptor antagonist (DALBK), inhibited the pruritogenic response to trypsin. Hoe 140 was also effective against SLIGRL-NH(2)-induced scratching behaviour when injected by i.d. or intrathecal (i.t.) routes. Also, the response to SLIGRL-NH(2) was inhibited by i.t. (but not by i.d.) treatment with DALBK. Conversely, neither Hoe 140 nor DALBK were able to inhibit SLIGRL-NH(2)-induced scratching behaviour when given intracerebroventricularly (i.c.v.). CONCLUSIONS AND IMPLICATIONS: The present results demonstrated that kinins acting on both B(1) and B(2) receptors played a crucial role in controlling the pruriceptive signalling triggered by PAR-2 activation in mice.
Authors: Nathalie Vergnolle; Mara Ferazzini; Michael R D'Andrea; Jörg Buddenkotte; Martin Steinhoff Journal: Trends Neurosci Date: 2003-09 Impact factor: 13.837
Authors: R O de Campos; R V Alves; J Ferreira; D J Kyle; S Chakravarty; B J Mavunkel; J B Calixto Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1999-09 Impact factor: 3.000
Authors: M Steinhoff; C U Corvera; M S Thoma; W Kong; B E McAlpine; G H Caughey; J C Ansel; N W Bunnett Journal: Exp Dermatol Date: 1999-08 Impact factor: 3.960
Authors: Martin Steinhoff; John Bienenstock; Martin Schmelz; Marcus Maurer; Ed Wei; Tamás Bíró Journal: J Invest Dermatol Date: 2006-08 Impact factor: 8.551
Authors: Robson Costa; Emerson M Motta; Rafael C Dutra; Marianne N Manjavachi; Allisson F Bento; Fernanda R Malinsky; João B Pesquero; João B Calixto Journal: Br J Pharmacol Date: 2011-09 Impact factor: 8.739
Authors: Eliziane S Patricio; Robson Costa; Claudia P Figueiredo; Katharina Gers-Barlag; Maíra A Bicca; Marianne N Manjavachi; Gabriela C Segat; Clive Gentry; Ana P Luiz; Elizabeth S Fernandes; Thiago M Cunha; Stuart Bevan; João B Calixto Journal: J Invest Dermatol Date: 2015-05-08 Impact factor: 8.551